Overview

IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer

Status:
Recruiting

Trial end date:
2025-10-01

Target enrollment:

Participant gender:

Summary

A open label 1:1 randomized phase II exploratory study investigating adjuvant therapy in patients with molecular biologically detectable residual disease after primary resection for localized colorectal tumors.

Phase:

Phase 2

Details

Lead Sponsor:

Karen-Lise Garm Spindler

Treatments:

Oxaliplatin